Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
Latest reported AUTL revenue for 2026-06-30 was $71.9M. Net income was -$110.7M. AUTL currently screens at market cap $614.8M.
Use this AUTL page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the AUTL quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the AUTL SEC filings page. Lician reads the product cache first so this HTML stays unique to Autolus Therapeutics Ltd even when a live quote feed is slow.
Latest cached year on this hub. Full AUTL income, balance, and cash tables.